Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background
Journal of Lipid Research · 2026-05 · 67 (5) · 101028
DOI: 10.1016/j.jlr.2026.101028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2026-05. Verfasst von José A Inia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands; Department of Cardiol…. Hauptthemen laut MEDLINE: Atherosclerosis, Atorvastatin, Ezetimibe, Receptors, LDL. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NewAmsterdam Pharma, TNO.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands; Department of Cardiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands;…
- Department of Biomedical Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands.
- NewAmsterdam Pharma, Naarden, the Netherlands.
- Department of Cardiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, LUMC, Leiden, the Netherlands; Netherlands Heart Institute, Utrecht, t…
- NewAmsterdam Pharma, Naarden, the Netherlands; Department of Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
- CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA; State University of New York, Downstate School of Public Health, Brooklyn, NY, USA.
Förderung
- NewAmsterdam Pharma
- TNO
Zitieren
APA
Inia, J. A., Zhang, L. H., Keijzer, N., Worms, N., van Nieuwkoop-van Straalen, A., Ditmarsch, M., de Kleer, M., Jukema, J. W., Kastelein, J. J. P., Szarek, M., van den Hoek, A. M., Stokman, G., Pieterman, E. J., & Princen, H. M. G. (2026). Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. Journal of Lipid Research, 67(5), 101028. https://doi.org/10.1016/j.jlr.2026.101028
Vancouver
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, et al. Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. Journal of Lipid Research. 2026;67(5):101028. doi:10.1016/j.jlr.2026.101028
BibTeX
@article{Inia2026,
author = {Inia, José A and Zhang, Leo H and Keijzer, Nanda and Worms, Nicole and van Nieuwkoop-van Straalen, Anita and Ditmarsch, Marc and de Kleer, Mathijs and Jukema, J Wouter and Kastelein, John J P and Szarek, Michael and van den Hoek, Anita M and Stokman, Geurt and Pieterman, Elsbet J and Princen, Hans M G},
title = {Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background},
journal = {Journal of Lipid Research},
year = {2026},
volume = {67},
number = {5},
pages = {101028},
doi = {10.1016/j.jlr.2026.101028}
}
EUVIMED